Credo Technology Group Holding Limited header image

Credo Technology Group Holding Limited

CRDO

Equity

ISIN KYG254571055 / Valor 116145651

NASDAQ (2026-08-05)
USD 224.63-5.59%

Credo Technology Group Holding Limited
UMushroom community rating:

star star star star star
4.25 4 votes No rating yet
NegativeNeutralPositive

About company

Credo Technology Group Holding Limited is a semiconductor company that specializes in high-speed connectivity solutions for electronic and communication systems. The company offers a range of products, including SerDes IP cores, retimer integrated circuits, and system-level Active Electrical Cables (AEC), which facilitate reliable data transmission in various applications. A notable product in their lineup is the Predictive Integrity Link Optimization and Telemetry (PILOT) software development kit, designed to accelerate system integration, provide comprehensive monitoring of PCIe link performance, and deliver predictive analysis to address signal integrity issues before they lead to system-level failures. By focusing on advanced diagnostic and telemetry capabilities, Credo Technology aims to enhance link reliability and system uptime, serving sectors such as high-performance computing and data centers with robust connectivity solutions.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (31.07.2026):

Credo Technology Group Holding Limited — Fourth Quarter of Fiscal Year 2026: Credo reported Q4 FY2026 revenue of $437.0 million (up 7.4% quarter‑over‑quarter and 157.0% year‑over‑year), GAAP net income of $169.1 million (GAAP diluted EPS $0.88) and non‑GAAP net income of $226.7 million (non‑GAAP diluted EPS $1.16). GAAP gross margin was 68.2% (non‑GAAP 68.3%). Ending cash plus short‑term investments totaled about $1.4 billion. Management provided Q1 FY2027 guidance and reiterated strong full‑year momentum.

Revenue & growth

Q4 FY2026 revenue $437.0M (+7.4% QoQ, +157.0% YoY). Fiscal 2026 revenue was $1.335 billion (more than tripled vs. FY2025).

Profitability

Q4 GAAP net income $169.1M (GAAP diluted EPS $0.88). Non‑GAAP Q4 net income $226.7M (non‑GAAP diluted EPS $1.16). Q4 GAAP gross margin 68.2% / non‑GAAP gross margin 68.3%.

Expenses & margins

Q4 GAAP operating expenses $142.2M; Q4 non‑GAAP operating expenses $81.7M. Q4 GAAP operating income $155.8M (35.7% margin); Q4 non‑GAAP operating income $216.7M (49.6% margin).

Liquidity & balance sheet

Ending cash and short‑term investments ≈ $1.44B (cash $1,164.95M + short‑term investments $278.33M). Total assets $2.296B and shareholders’ equity $2.064B at May 2, 2026.

Full‑year FY2026 highlights

Fiscal 2026 revenue $1.335B and GAAP net income $472.3M. Non‑GAAP net income for FY2026 was $661.5M (~$662M as cited by management), and non‑GAAP net income margin for the year ~49.5%.

Q1 FY2027 outlook

Management expects Q1 FY2027 revenue $465.0M–$475.0M; GAAP gross margin 66.9%–68.9% (non‑GAAP 67.0%–69.0%); GAAP operating expenses $167.6M–$171.6M (non‑GAAP operating expenses $86.0M–$90.0M).

Non‑GAAP adjustments

Non‑GAAP results exclude share‑based compensation, acquisition/integration costs, amortization of acquired intangibles and impairment charges; these adjustments materially raise reported non‑GAAP profitability versus GAAP in Q4 and FY2026.

Summarized from source with an LLMView Source

Key figures

104%1Y
1,266%3Y
%5Y

Performance

89.7%1Y
83.3%3Y
83.4%5Y

Volatility

Market cap

41889 M

Market cap (USD)

Daily traded volume (Shares)

4,281,972

Daily traded volume (Shares)

1 day high/low

71.05 / 66.95

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.25

4 votes
Performance:
starstarstarstarstar
4.75
Innovation:
starstarstarstarstar
4.25
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
2.25
William Gonzalez
UK, 04 Nov 2025
star star star star star
nice
sofia nava
Switzerland, 01 Nov 2025
star star star star star
.
Ching Chang
Switzerland, 30 Oct 2025
star star star star star
strong performance

EQUITIES OF THE SAME SECTOR

Topicus.com Inc
Topicus.com Inc Topicus.com Inc Valor: 57260697
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.76%CAD 103.90
Sage Group PLC
Sage Group PLC Sage Group PLC Valor: 21381483
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.35%GBP 10.13
Check Point Software Technologies Ltd
Check Point Software Technologies Ltd Check Point Software Technologies Ltd Valor: 494683
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.15%USD 125.35
Teradyne Inc
Teradyne Inc Teradyne Inc Valor: 976541
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.51%USD 389.39
Adeia Inc
Adeia Inc Adeia Inc Valor: 121680853
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.17%USD 29.91
United Therapeutics Corp
United Therapeutics Corp United Therapeutics Corp Valor: 848383
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%USD 519.01
Peloton Interactive Inc
Peloton Interactive Inc Peloton Interactive Inc Valor: 49767034
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.36%USD 6.52
Affirm Holdings Inc
Affirm Holdings Inc Affirm Holdings Inc Valor: 58463675
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%USD 78.47
Vaxcyte Inc
Vaxcyte Inc Vaxcyte Inc Valor: 54991636
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.25%USD 55.92
Blackbuck Ltd
Blackbuck Ltd Blackbuck Ltd Valor: 139855196
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.80%INR 556.45